Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile



4550 Towne Centre Court

San Diego  California  92121  U.S.A.
Phone: 858-558-7500 Fax: 858-552-8775

Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide.

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.

Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), small-cell lung and prostate cancer.

As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

 Key Statistics

Ownership: Subsidiary

Web Site: Celgene
Employees: 2,000 worldwide
Symbol: CELG



Novartis Corporation  Discovery and Development of Selective estrogen receptor modulators for the treatment of osteoporosis

Novartis Corporation  Commercialization of FocalinTM for ADHD

 Company News
Alliqua, Inc. (ALQA) To Launch Biovance® Human Amniotic Membrane Allograft Product Licensed From Celgene (CELG) 4/23/2014 9:24:32 AM    More...
Why People Love Working For Big Pharmas Like Biogen Idec, Inc. (Massachusetts) (BIIB), Celgene (CELG), And Gilead Sciences, Inc. (GILD) 4/18/2014 7:53:43 AM    More...
FORMA Therapeutics, Inc. Picks Up Another $225 Million, And A Potential Buyout From Celgene (CELG) 4/1/2014 7:07:07 AM    More...
Celgene (CELG) Release: Oral OTEZLA® (Apremilast) Demonstrated Clinically Meaningful And Sustained Improvements In Skin, Nail And Scalp Of Adult Patients With Moderate To Severe Plaque Psoriasis 3/24/2014 9:11:55 AM    More...
National Institute of Clinical Research Turns Down Celgene (CELG)'s Revlimid 3/17/2014 7:34:11 AM    More...
San Diego Startup Abide Therapeutics Strikes Immune Disorder Pact With Celgene (CELG), Financial Details Undisclosed 2/28/2014 7:38:15 AM    More...
Nuvilex's Pancreatic Cancer Treatment Readies To Challenge Eli Lilly and Company (LLY) And Celgene (CELG) In Late-Phase Clinical Trials 2/19/2014 10:14:43 AM    More...
Agios Pharmaceuticals Exercises Option To U.S. Development And Commercialization Rights For IDH1 Program Under Celgene (CELG) Collaboration 2/3/2014 9:05:14 AM    More...
Acceleron Pharma Earns $7 Million Milestone Payment For Celgene (CELG)’s Initiation Of Sotatercept Phase 2 Clinical Trial In Patients With End Stage Renal Disease On Hemodialysis 12/18/2013 9:40:21 AM    More...
Agios Pharmaceuticals Advances Cancer Metabolism Collaboration With Celgene (CELG) 12/11/2013 9:13:33 AM    More...